# Lysophosphatidylglycerol in Asthma Pathogenesis

> **NCT06327516** · — · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06327516
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06327516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06327516, "Lysophosphatidylglycerol in Asthma Pathogenesis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06327516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*